Cue Biopharma Inc FCF yield
What is the FCF yield of Cue Biopharma Inc?
The FCF yield of Cue Biopharma Inc is -30.40%
What is the definition of FCF yield?
Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.
ttm (trailing twelve months)
Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.
Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:
Free cash flow yield = Free cash flow per share / market price per share
FCF yield of companies in the Health Care sector on NASDAQ compared to Cue Biopharma Inc
What does Cue Biopharma Inc do?
cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci
Companies with fcf yield similar to Cue Biopharma Inc
- Golden Bull has FCF yield of -30.63%
- Tembo Gold has FCF yield of -30.59%
- Helius Medical Technologies has FCF yield of -30.54%
- Ngm Biopharmaceuticals Inc has FCF yield of -30.52%
- Avalon Advanced Materials has FCF yield of -30.52%
- Taizhou Water Co has FCF yield of -30.45%
- Cue Biopharma Inc has FCF yield of -30.40%
- iCandy Interactive has FCF yield of -30.35%
- Strip Tinning Plc Ord has FCF yield of -30.34%
- goeasy has FCF yield of -30.33%
- Codrus Minerals has FCF yield of -30.32%
- Optimum Ventures has FCF yield of -30.31%
- Namaste Technologies has FCF yield of -30.28%